Literature DB >> 19151334

Signal transducer and activator of transcription 3 is a transcriptional factor regulating the gene expression of SALL4.

J Dien Bard1, P Gelebart, H M Amin, L C Young, Y Ma, R Lai.   

Abstract

Both signal transducer and activator of transcription 3 (STAT3) and SALL4 are important in maintaining the pluripotent and self-renewal state of embryonic stem cells. We hypothesized that STAT3, a latent transcriptional factor, may regulate the gene expression of SALL4. In support of this hypothesis, DNA sequence analysis of the SALL4 gene promoter revealed four putative STAT3-binding sites. Using a SALL4-luciferase reporter gene assay, we found that modulation of the STAT3 activity significantly up-regulated the luciferase activity. By chromatin immunoprecipitation, the segment of the SALL4 promoter showing the highest affinity to STAT3 was localized to -366 to -163, in which there was only one putative STAT3 binding site starting at -199. Site-directed mutagenesis of all four putative STAT3-binding sites in the SALL4 promoter significantly reduced its responsiveness to STAT3, although the most dramatic effect was seen at the binding site starting at -199. We further tested the functional relationship between STAT3 and SALL4 using MDA-MB-231, a breast cell line carrying constitutive SALL4 expression and STAT3 activity. Down-regulation of the STAT3 activity using a dominant-negative construct resulted in a significant decrease in the expression of SALL4. To conclude, our data suggest that STAT3 and SALL4 probably cooperate in both physiological and pathological states.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19151334     DOI: 10.1096/fj.08-117721

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  22 in total

1.  Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif-containing 21.

Authors:  Junji Itou; Wenzhao Li; Shinji Ito; Sunao Tanaka; Yoshiaki Matsumoto; Fumiaki Sato; Masakazu Toi
Journal:  J Biol Chem       Date:  2018-03-06       Impact factor: 5.157

2.  Transcriptional and post-translational regulation of the quiescence factor and putative tumor suppressor p150(Sal2).

Authors:  Chang K Sung; Jean Dahl; Hyungshin Yim; Scott Rodig; Thomas L Benjamin
Journal:  FASEB J       Date:  2011-01-12       Impact factor: 5.191

Review 3.  The role of stem cell factor SALL4 in leukemogenesis.

Authors:  Chong Gao; Nikki R Kong; Li Chai
Journal:  Crit Rev Oncog       Date:  2011

4.  STAT3 upregulates the protein expression and transcriptional activity of β-catenin in breast cancer.

Authors:  Hanan Armanious; Pascal Gelebart; John Mackey; Yupo Ma; Raymond Lai
Journal:  Int J Clin Exp Pathol       Date:  2010-07-25

5.  Notch1-STAT3-ETBR signaling axis controls reactive astrocyte proliferation after brain injury.

Authors:  Matthew D LeComte; Issei S Shimada; Casey Sherwin; Jeffrey L Spees
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

Review 6.  SALL4, the missing link between stem cells, development and cancer.

Authors:  Hiro Tatetsu; Nikki R Kong; Gao Chong; Giovanni Amabile; Daniel G Tenen; Li Chai
Journal:  Gene       Date:  2016-02-16       Impact factor: 3.688

Review 7.  Functional and clinical significance of SALL4 in breast cancer.

Authors:  Ebubekir Dirican; Mustafa Akkiprik
Journal:  Tumour Biol       Date:  2016-07-21

8.  Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.

Authors:  Fei Yin; Xin Han; Shu-Kun Yao; Xiao-Ling Wang; Hui-Chai Yang
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

9.  Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex.

Authors:  Chong Gao; Todor Dimitrov; Kol Jia Yong; Hiro Tatetsu; Ha-won Jeong; Hongbo R Luo; James E Bradner; Daniel G Tenen; Li Chai
Journal:  Blood       Date:  2013-01-03       Impact factor: 22.113

10.  Regulation of PSMB5 protein and β subunits of mammalian proteasome by constitutively activated signal transducer and activator of transcription 3 (STAT3): potential role in bortezomib-mediated anticancer therapy.

Authors:  Janakiram Reddy Vangala; Srikanth Dudem; Nishant Jain; Shasi V Kalivendi
Journal:  J Biol Chem       Date:  2014-03-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.